Skip to main content
. 2019 May 8;17(4):eGS4444. doi: 10.31744/einstein_journal/2019GS4444

Table 3. Prescribed days of drug therapy according to medication of the therapeutic systemic antibacterial subgroup.

Antimicrobial Pre-infection period
n (%)
Infection period
n (%)
Post-infection period
n (%)
Full period
n (%)
Amikacin 80 (2.6) 546 (13.8) 93 (13.1) 719 (9.2)
Amoxicillin 99 (3.2) 71 (1.8) 8 (1.1) 178 (2.3)
Ampicillin 28 (0.9) 22 (0.6) 14 (2.0) 64 (0.8)
Ampicillin, combinations 87 (2.8) 99 (2.5) 23 (3.2) 209 (2.7)
Azithromycin 30 (1.0) 12 (0.3) - 42 (0.5)
Benzylpenicillin 1 (0.0) 1 (0.0) 3 (0.4) 5 (0.1)
Cefazolin 75 (2.4) 32 (0.8) - 107 (1.4)
Cefepime 139 (4.4) 103 (2.6) 103 (14.5) 345 (4.4)
Ceftazidime 13 (0.4) 18 (0.5) - 31 (0.4)
Ceftriaxone 192 (6.1) 99 (2.5) 14 (2.0) 305 (3.9)
Cefuroxime 4 (0.1) 19 (0.5) - 23 (0.3)
Ciprofloxacin 74 (2.3) 38 (1.0) 6 (0.8) 118 (1.5)
Clindamycin 168 (5.4) 48 (1.2) 1 (0.1) 217 (2.8)
Daptomycin - 88 (2.2) - 88 (1.1)
Ertapenem - 50 (1.3) 14 (2.0) 64 (0.8)
Erythromycin - 1 (0.0) - 1 (0.0)
Gentamicin 7 (3.1) 28 (0.7) 12 (1.7) 137 (1.8)
Imipenem and enzyme inhibitor 3 (0.1) 11 (0.3) - 14 (0.2)
Levofloxacin 54 (1.7) 67 (1.7) 7 (1.0) 128 (1.6)
Linezolid 78 (2.5) 30 (0.8) 21 (3.0) 129 (1.7)
Meropenem 478 (15.2) 843 (21.2) 94 (13.2) 1,415 (18.1)
Metronidazole 265 (8.5) 223 (5.6) 64 (9.0) 552 (7.1)
Nitrofurantoin - 12 (0.3) - 12 (0.2)
Oxacillin 86 (2.7) 53 (1.3) - 139 (1.8)
Piperacillin and enzyme inhibitor 298 (9.5) 179 (4.5) 9 (1.3) 486 (6.2)
Polymyxin B 117 (3.7) 437 (11.0) 77 (10.8) 631 (8.1)
Sulfamethoxazole and trimethoprim 65 (2.1) 144 (3.6) 77 (10.8) 286 (3.7)
Teicoplanin 128 (4.1) 99 (2.5) - 227 (2.9)
Tigecycline - 83 (2.1) 3 (0.4) 86 (1.1)
Tobramycin 13 (0.4) 5 (0.1) 3 (0.4) 21 (0.3)
Vancomycin 463 (14.8) 507 (12.8) 65 (9.1) 1,035 (13.2)
Total 3.135 3.968 711 7.814